{"id":"NCT02413398","sponsor":"AstraZeneca","briefTitle":"A Study to Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 Diabetes","officialTitle":"A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group, Randomized, Phase III Study to Evaluate the Glycemic Efficacy and Renal Safety of Dapagliflozin in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment (CKD 3A) Who Have Inadequate Glycemic Control.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-06-15","primaryCompletion":"2017-11-07","completion":"2017-11-07","firstPosted":"2015-04-09","resultsPosted":"2018-10-31","lastUpdate":"2018-10-31"},"enrollment":321,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Dapagliflozin 10 mg","otherNames":["Farxigaâ„¢"]},{"type":"DRUG","name":"Matching Placebo for Dapagliflozin","otherNames":[]}],"arms":[{"label":"Dapagliflozin","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this clinical research study is to determine whether dapagliflozin can improve (decrease) blood glucose values in patients with Type 2 diabetes and moderate renal impairment.This study will be conducted at approximately 100 centres from countries across North America and European regions. It is planned to randomize a total of 302 patients.","primaryOutcome":{"measure":"Adjusted Mean Change From Baseline in Hemoglobin A1c (HbA1c) at Week 24","timeFrame":"Baseline, Week 24","effectByArm":[{"arm":"Dapagliflozin","deltaMin":-0.37,"sd":0.1},{"arm":"Placebo","deltaMin":-0.03,"sd":0.1}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":8},"locations":{"siteCount":87,"countries":["United States","Bulgaria","Canada","Czechia","Italy","Poland","Spain","Sweden"]},"refs":{"pmids":["38770818","29888547"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=3689&filename=D1690C00024-Clinical%20Study%20Protocol-v%204.0_redacted_final_1.pdf","http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=3689&filename=D1690C00024-Statistical-Analysis-Plan-Edition-2_redacted_final_PDF_A.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":160},"commonTop":[]}}